Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Lung Cancer, Nonsmall Cell

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Mel V, BA) · Melissa.volpe@pennmedicine.upenn.edu · 215-220-9703
Contact: Principal Investigator (Melina Marmarelis, MD, MSCE)

Study leads

Melina Marmarelis, MD, MSCE
Principal Investigator
Abramson Cancer Center at Penn Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Cancer · PDAC - Pancreatic Ductal Adenocarcinoma · NSCLC (Non-small Cell Lung Cancer)

Abroad (travel likely)RecruitingPHASE1

Orlando, United States · Boston, United States

Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer

Lung Cancer · Lung Cancer Metastatic · Brain Metastases

Abroad (travel likely)RecruitingPHASE1

Sacramento, United States

The Development, Safety, and Feasibility of an Artificial Intelligence-Powered Platform (NodeAI) for Real-Time Prediction of Mediastinal Lymph Node Malignancy During Endobronchial Ultrasound Staging for Lung Cancer

Lung Cancer · Non Small Cell Lung Cancer

Abroad (travel likely)Recruiting

Hamilton, Canada

The Associations of Sleep Disturbance With Therapy Efficacy and Prognosis of Lung Cancer

Lung Cancer · Sleep Disturbance · Immune Checkpoint Inhibitors

Abroad (travel likely)Recruiting

Changsha, China